Building a coordinated access model is no longer just a difference – it’s a competitive necessity.

BLOG
Building a coordinated access model is no longer just a difference – it’s a competitive necessity.
A well-designed framework ensures that every step is appropriately structured to eliminate unnecessary delays.
Why Understanding the Product Access Journey is Essential for Patient Support Success
As 2024 draws to a close, Archbow Consulting reflects on a year of dynamic change within the pharmaceutical industry.
Why manufacturers must embrace innovative trends to stay ahead
Understanding the opportunity to sell directly to patients via a cash model
An Interview on Best Practices and Trends in 2025
Designing a pharmaceutical hub for combination or companion products is a complex undertaking that requires careful planning and design execution.
Pharmaceutical manufacturers have many partner choices in today’s competitive Specialty Pharmacy (SP) space. By focusing on the following key areas, SPs can elevate their value proposition and drive mutual success.
Biotech marketing requires a unique blend of scientific expertise, strategic planning, and creative execution.
Navigate the open road ahead with confidence. Start planning today and ensure your 2025 program delivers the support your patients need.
Pre-Asembia Checklist for Market Access Teams
What to Do When Your Brand Sees a Sudden Rise in Copay Costs
Is a Direct-to-Patient Access Model Viable For My Product?
Hub Implementation: The Key to Product Launches
Don’t Let Your Pharma Program Fall Behind – Optimize It Now
The Key to Pharmaceutical Commercial Success
Case Study: Fresh Approach to HUB Communications Drives 20% User Growth
HUBs are Underutilized; Yours Doesn’t Have to Be
Key Takeaways from the Health Systems & Pharma Partnering Summit 2023
The Perils of Pull-Through
6 Essential Strategies for Successful Clinical Adherence
Product Acquistion (Buy and Bill vs. Specialty Pharmacy) is a key factor in determining which services a HUB should offer
Take the Pain out of Conversations About Coverage
Key Takeaways from the 2023 Asembia Specialty Pharmacy Summit
How Manufacturers Can Optimize Hub Services
Best Practices for Vendor Selection and Management
Essential Program Takeaways from the 2023 ECRM Conference
Our experts teamed up with Pharmaceutical Executive to identify 10 Market Access Trends to Watch for in 2023, spanning patients, prescribers
Manufacturers recognize access and affordability programs as key differentiators that build brand loyalty with elevated customer experiences
Webinar Archive: Get answers to the eleven key questions that will help guide commercial teams in effectively launching specialty products.
The key to building an integrated model for new products is understanding which steps in launch planning are essential and when to take them
With the right approach, patient support programs can mitigate the potential negative impacts of regulatory compliance
Practical lists of questions spanning distribution, access, and affordability that market access teams can use to impact health equity today
In celebration of Nurses Day, explore how nurses working for pharmaceutical consulting companies benefit manufacturers’ commercial goals
Poor quality within a HUB can lead to delays in patient treatment, loss of prescriber confidence, and users seeking alternative avenues.
It is vital for pharmaceutical manufacturers to consider how much financial and reputational risk they may face as a result of the pending C
We often advise our clients that there are many varied ways to better understand and engage with rare disease patients.
A seasoned patient services leader offers guidance on where to focus, how to best align resources, and when and where to ask for help.